SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC)
13 references·0 citing·45 second hop
Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC) (2008)Comparative clinical and economic outcome…Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Using and interpreting cost-e…Do Oncologists Believe New Cancer Drugs Offer Good Value? (2006)Do Oncologists Believe New Ca…Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer (2002)Economic Analysis of Vinorelb…Economic Analysis of the TAX 317 Trial: Docetaxel Versus Best Supportive Care as Second-Line Therapy of Advanced Non-Small-Cell Lung Cancer (2002)Economic Analysis of the TAX …The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)The Burden of Illness of Canc…Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Representing uncertainty: the…Systematic Overview of Cost-Utility Assessments in Oncology (2000)Systematic Overview of Cost-U…Handling Uncertainty in Cost-Effectiveness Models (2000)Handling Uncertainty in Cost-…Economic foundations of cost-effectiveness analysis (1997)Economic foundations of cost-…Cost of care for cancer in a health maintenance organization. (1997)Cost of care for cancer in a …Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Economic Foundations of Cost Effective Analysis (1992)Economic Foundations of Cost …Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Probabilistic Sensitivity Ana…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope (2006)Economic evaluation of a task-shifting intervention for common mental disorders in India (2012)Health economic evaluation: Important principles and methodology (2013)EuroQol - a new facility for the measurement of health-related quality of life (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Health Care Economic Analyses and Value-Based Medicine (2003)HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis (2004)Health Utilities Using the EQ-5D in Studies of Cancer (2007)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Judgment under Uncertainty: Heuristics and Biases (1974)Clinical Decision Analysis (1980)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Measurement of health state utilities for economic appraisal (1986)Markov Models in Medical Decision Making (1993)Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease (2002)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. (1992)The burden of illness associated with hepatocellular carcinoma in the United States (2008)Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States (2015)Global treatment costs of breast cancer by stage: A systematic review (2018)The economic costs of illness: a replication and update. (1985)Toward Consistency in Cost-Utility Analyses (1998)Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000 (2004)The financial burden of cancer: estimates from a study of insured women with breast cancer. (2004)Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014 (2018)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial (2009)Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists (2010)Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists (2013)Risk Aversion in the Small and in the Large (1964)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2002)Methods for the Economic Evaluation of Health Care Programmes (2005)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2001Representing uncertainty: the role of cost‐effectiveness acceptability curves1,111 cited
  • 1985Probabilistic Sensitivity Analysis Using Monte Carlo Simulation860 cited
  • 2000Handling Uncertainty in Cost-Effectiveness Models806 cited
  • 1997Economic foundations of cost-effectiveness analysis767 cited
  • 2001The Burden of Illness of Cancer: Economic Cost and Quality of Life309 cited
  • 2000Systematic Overview of Cost-Utility Assessments in Oncology296 cited
  • 2006Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation279 cited
  • 1997Cost of care for cancer in a health maintenance organization.196 cited
  • 2006Do Oncologists Believe New Cancer Drugs Offer Good Value?187 cited
  • 1992Economic Foundations of Cost Effective Analysis90 cited
  • 2002Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung Cancer74 cited
  • 2002Economic Analysis of the TAX 317 Trial: Docetaxel Versus Best Supportive Care as Second-Line Therapy of Advanced Non-Small-Cell Lung Cancer71 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work